Page last updated: 2024-09-04

ezetimibe and Hepatitis C

ezetimibe has been researched along with Hepatitis C in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Azhar, A; Balaraman, V; Bhalla, A; Binari, LA; Concepcion, BP; Eason, JD; Forbes, RC; Hall, IE; Joglekar, K; Molnar, MZ; Rofaiel, G; Shaffer, D; Talwar, M; Tsujita, M1
Chung, RT; Holmes, JA1
López-Lastra, M; Monrroy, H; Soza, A1
Alrefai, WA; Barretto, N; Chayama, K; Hiraga, N; Hussain, S; Imamura, M; Marsh, KA; Martin, DN; Sainz, B; Uprichard, SL; Yu, X1
Colotto, M; Durante, C; Renzi, A1
Del Campo, JA; Rojas, Á; Romero-Gómez, M1

Other Studies

6 other study(ies) available for ezetimibe and Hepatitis C

ArticleYear
Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys.
    Clinical transplantation, 2021, Volume: 35, Issue:12

    Topics: Antiviral Agents; Ezetimibe; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Kidney; Kidney Transplantation; Retrospective Studies; RNA; Tissue Donors; Transplant Recipients

2021
Shortening treatment with direct-acting antivirals in HCV-positive organ transplantation.
    The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:7

    Topics: Antiviral Agents; Ezetimibe; Hepatitis C; Hepatitis C, Chronic; Humans; Organ Transplantation

2020
Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe.
    Medical hypotheses, 2017, Volume: 102

    Topics: Anti-HIV Agents; Anticholesteremic Agents; Cholesterol; Ezetimibe; Hepacivirus; Hepatitis C; Humans; Intestines; Liver; Membrane Proteins; Membrane Transport Proteins; Models, Biological; Virus Internalization

2017
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.
    Nature medicine, 2012, Jan-08, Volume: 18, Issue:2

    Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Ezetimibe; Hepacivirus; Hepatitis C; Humans; Male; Membrane Transport Proteins; Mice; Virus Internalization

2012
Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk.
    BMJ case reports, 2012, Jul-17, Volume: 2012

    Topics: Acromegaly; Adenoma; Adult; Azetidines; Cardiovascular Diseases; Coinfection; Ezetimibe; Female; Fluorobenzenes; Hepatitis C; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Magnetic Resonance Imaging; Pituitary Neoplasms; Pyrimidines; Risk Factors; Rosuvastatin Calcium; Sulfonamides

2012
Entry of hepatitis C virus into the cell: a therapeutic target.
    World journal of gastroenterology, 2012, Sep-07, Volume: 18, Issue:33

    Topics: Anticholesteremic Agents; Azetidines; Cell Membrane; Ezetimibe; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Lipid Metabolism; Membrane Proteins; Membrane Transport Proteins; Receptors, Cell Surface; Virus Internalization

2012